Radiation toxicity is an illness and symptom resulting from excessive exposure to radiations. Radiation exposure can occur as a single large exposure (acute), or a series of small exposures spread over time (chronic). Exposure may be accidental or intentional (as in radiation therapy). Exposure to high amount of radiation causes degradation of DNA and other key molecular structures within cells in various tissues. The destruction of DNA ultimately affects normal replication of the cells. Exposure to smaller dose of radiation results in symptoms such as gastrointestinal disturbances including nausea and vomiting. While exposure to higher dose of radiation reflects symptoms such as neuro damage and rapid death. Unfortunately, giving first aid to radiation victims may expose rescue personnel to radiation unless they are properly protected. Thus, the increasing level of radiation toxicity that harm to human health globally has grabbed the attention of pharmaceutical companies to invest into radiation toxicity market.
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market: Drivers and Restraints
Increasing use of radiation therapy and nuclear medicine in the treatment and diagnosis of diseases is one of the major driver for the growth of radiation toxicity (radiation sickness, acute radiation syndrome) market. However, the high cost of treatment would hinder the growth of radiation toxicity (radiation sickness, acute radiation syndrome) market over the forecasted period.
RadiationToxicity (Radiation Sickness, Acute Radiation Syndrome) Market: Segmentation
The global radiation toxicity (radiation sickness/acute radiation syndrome) market is segmented based on type of radiation, disease, and drugs.
Based on radiation type, the global radiation toxicity (radiation sickness, acute radiation syndrome) market is segmented into the following:
• Ionizing...